Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Pfizer”

Study Evaluating Single Doses Of SBI-087 in Subjects With Rheumatoid ArthritisCompleted
NCT00641225Phase 1Updated Sep 13, 2023
Sponsor: Pfizer
Rheumatoid Arthritis
United States, Canada
Imaging for the Evaluation of Transthyretin Cardiac Amyloidosis Prevalence of Patients Over 65 Hospitalized in Cardiology Wards (the IMPACT Study)Completed
NCT05064839Phase 3Updated Sep 11, 2023
Sponsor: Poitiers University Hospital
Transthyretin Cardiac Amyloidosis
France
Safety And Efficacy Study Of Palbociclib Plus Cetuximab Versus Cetuximab To Treat Head And Neck CancerCompleted
NCT02499120Phase 2Updated Sep 8, 2023
Sponsor: Pfizer
Squamous Cell Carcinoma of the Head and Neck (SCCHN)
United States, Czechia, Hungary, Italy, Japan +10 more
PALbociclib Rechallenge in horMone Receptor-posItive/HER2- Negative Advanced Breast Cancer (PALMIRA)Completed
NCT03809988Phase 2Updated Sep 7, 2023
Sponsor: MedSIR
Breast Cancer · Advanced Breast Cancer · Hormone Receptor Positive Tumor · Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
France, Germany, Italy, Slovenia, Spain +1 more
Avelumab, Palbociclib and Axitinib in Advanced RCCWithdrawn
NCT05176288Phase 2Updated Sep 7, 2023
Sponsor: Bradley A. McGregor, MD
Advanced Clear Cell Renal Cell Carcinoma
Study to Estimate the Effects of Hepatic Impairment on the Pharmacokinetics (PK) of PF-07321332Completed
NCT05005312Phase 1Updated Sep 6, 2023
Sponsor: Pfizer
Hepatic Impairment
United States
Investigation to Minimize Prolapse Recurrence of the Vagina Using EstrogenCompleted
NCT02431897Phase 4Updated Sep 6, 2023
Sponsor: University of Texas Southwestern Medical Center
Pelvic Organ Prolapse · Urogenital Prolapse · Vaginal Vault Prolapse · Cystocele
United States
Gemtuzumab Ozogamicin With G-CSF, Cladribine, Cytarabine & Mitoxantrone for Untreated AML & High-Grade Myeloid NeoplasmCompleted
NCT03531918Phase 1, Phase 2Updated Aug 30, 2023
Sponsor: Fred Hutchinson Cancer Center
Acute Myeloid Leukemia
United States
Safety And Efficacy Study Of Avelumab Plus Chemotherapy With Or Without Other Anti-Cancer Immunotherapy Agents In Patients With Advanced MalignanciesTerminated
NCT03317496Phase 1, Phase 2Updated Aug 29, 2023
Sponsor: Pfizer
Non-small Cell Lung Cancer · Urothelial Cancer
United States, Australia, Canada, Czechia, Hungary +3 more
ACTIV-3: Therapeutics for Inpatients With COVID-19Completed
NCT04501978Phase 3Updated Aug 25, 2023
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Covid19
United States, Denmark, Greece, Nigeria, Poland +5 more
Phase I Study of Inotuzumab With Augmented BFM Re-Induction for Patients With Relapsed/Refractory B-cell ALLUnknown
NCT03962465Phase 1Updated Aug 22, 2023
Sponsor: University of Virginia
B-cell Acute Lymphoblastic Leukemia
United States
PF-00299804 in Stage IIIB or Stage IV Non-Small Cell Lung Cancer Not Responding to Standard Therapy for Advanced or Metastatic CancerCompleted
NCT01000025Phase 3Updated Aug 22, 2023
Sponsor: NCIC Clinical Trials Group
Lung Cancer
United States, Argentina, Australia, Brazil, Canada +7 more
A Drug-Drug Interaction Study Between PF-06882961 and PF-06865571 in Healthy Adult Participants and Overweight Adults or Adults With Obesity Who Are Otherwise HealthyCompleted
NCT04839393Phase 1Updated Aug 21, 2023
Sponsor: Pfizer
Healthy Volunteer
United States
A Single Dose Study To Test Two Pediatric Forms Of Ritlecitinib Compared With Adult Ritlecitinib In Healthy AdultsCompleted
NCT05040295Phase 1Updated Aug 21, 2023
Sponsor: Pfizer
Healthy Participants
United States
Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR).Terminated
NCT05011513Phase 2, Phase 3Updated Aug 14, 2023
Sponsor: Pfizer
COVID-19
United States, Argentina, Brazil, Bulgaria, Colombia +15 more
GEN-001 (Live Biotherapeutic Product) and Avelumab Combination Study for Patients With Solid Tumors Who Have Progressed on Anti-PD-(L)1 TherapyCompleted
NCT04601402Phase 1Updated Aug 8, 2023
Sponsor: Genome & Company
Solid Tumor · Non Small Cell Lung Cancer · Squamous Cell Carcinoma of Head and Neck · Urothelial Carcinoma
United States
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to <26 Years of Age.Completed
NCT03135834Phase 3Updated Aug 8, 2023
Sponsor: Pfizer
Meningococcal Vaccine
United States, Czechia, Finland, Poland
A Phase II Study of PF-03446962 in Patients With Advanced Malignant Pleural MesotheliomaCompleted
NCT01486368Phase 2Updated Aug 4, 2023
Sponsor: NCIC Clinical Trials Group
Malignant Pleural Mesothelioma
Canada
P13Kinase Inhibitor BKM120 in Combination With Panitumumab in Metastatic/Advanced RAS-Wild Type Colorectal Cancer.Completed
NCT01591421Phase 1, Phase 2Updated Aug 4, 2023
Sponsor: Canadian Cancer Trials Group
Metastatic Colorectal Cancer
Canada
Vinblastine and Temsirolimus in Pediatrics With Recurrent or Refractory Lymphoma or Solid Tumours Including CNS TumoursCompleted
NCT02343718Phase 1Updated Aug 4, 2023
Sponsor: Canadian Cancer Trials Group
Recurrent Lymphoma · Refractory Lymphoma · Solid Tumours · Central Nervous System
Canada
A Pilot Study of eHealth Tools in a Tertiary-care SettingCompleted
NCT03762460NAUpdated Aug 3, 2023
Sponsor: University of British Columbia
Depression
Canada
Treatment Patterns and Bleeding Risk of Anticoagulants in Patients With Venous Thromboembolism in KoreaCompleted
NCT05022563N/AUpdated Aug 3, 2023
Sponsor: Pfizer
Venous Thromboembolism
South Korea
Renal Impairment Study of PF-07321332 Boosted With Ritonavir in Adult Participants With Renal Impairment and in Healthy Participants With Normal Renal Function.Completed
NCT04909853Phase 1Updated Aug 2, 2023
Sponsor: Pfizer
Renal Impairment
United States
Study to Assess the Pharmacokinetics, Safety and Tolerability of Aztreonam-Avibactam in Healthy Chinese Participants.Completed
NCT04973826Phase 1Updated Jul 28, 2023
Sponsor: Pfizer
Healthy
China
Pharmacokinetic Study of Aztreonam-Avibactam in Severe Renal ImpairmentCompleted
NCT04486625Phase 1Updated Jul 28, 2023
Sponsor: Pfizer
Renal Insufficiency
United States

Previous page Next page